NKE vs PG: Which Is the Better Buy?
Side-by-side comparison of NIKE, Inc. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
NIKE, Inc. · Consumer Cyclical
$45.20
+38.7% upside to fair value
Grade B
High Quality
VS
The Procter & Gamble Company · Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
NKE has more upside to fair value
(+38.7%).
PG trades at a lower forward P/E
(21.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NKE |
PG |
| Current Price |
$45.20 |
$150.38 |
| Fair Value Estimate |
$62.68 |
$165.39 |
| Upside to Fair Value |
+38.7%
|
+10.0%
|
| Market Cap |
$66.8B |
$350.2B |
| Forward P/E |
29.7x
|
21.5x
|
| EV / EBITDA |
19.4x
|
15.1x
|
| Price / Sales |
1.4x
|
4.0x
|
| Price / FCF |
63.8x
|
23.3x
|
| Revenue Growth YoY |
+0.1%
|
+7.4%
|
| Gross Margin |
40.8%
|
50.3%
|
| Operating Margin |
6.0%
|
23.2%
|
| Return on Equity |
16.4%
|
31.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.57%
|
4.29%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
NIKE, Inc. is the leading global athletic footwear and apparel brand with a strong competitive moat driven by its iconic brand and extensive innovation capabilities. The company is currently facing earnings pressure with a 34.5% decline in earnings in the most recent quarter and a 10% revenue decline in fiscal 2025, reflecting challenges from tariff-related cost pressures, intense competition, an…
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Accumulation Zones
| Metric |
NKE |
PG |
| Zone Low |
$47.01 |
$124.04 |
| Zone High |
$53.28 |
$140.58 |
| In Buy Zone? |
Yes
|
No
|